BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37882056)

  • 41. Immune-Desert Tumor Microenvironment in Thoracic SMARCA4-Deficient Undifferentiated Tumors with Limited Efficacy of Immune Checkpoint Inhibitors.
    Gantzer J; Davidson G; Vokshi B; Weingertner N; Bougoüin A; Moreira M; Lindner V; Lacroix G; Mascaux C; Chenard MP; Bertucci F; Davidson I; Kurtz JE; Sautès-Fridman C; Fridman WH; Malouf GG
    Oncologist; 2022 Jun; 27(6):501-511. PubMed ID: 35278076
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of Thoracic SMARCA4-Deficient Undifferentiated Tumors: Where We Are and Where We Will Go.
    Longo V; Catino A; Montrone M; Montagna ES; Pesola F; Marech I; Pizzutilo P; Nardone A; Perrone A; Gesualdo M; Galetta D
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542211
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ferret thoracic anatomy by 2-deoxy-2-(18F)fluoro-D-glucose (18F-FDG) positron emission tomography/computed tomography (18F-FDG PET/CT) imaging.
    Wu A; Zheng H; Kraenzle J; Biller A; Vanover CD; Proctor M; Sherwood L; Steffen M; Ng C; Mollura DJ; Jonsson CB
    ILAR J; 2012; 53(1):E9-21. PubMed ID: 23382267
    [TBL] [Abstract][Full Text] [Related]  

  • 44. SMARCA4-deficient thoracic sarcoma revealed by metastasis to the small intestine: a diagnostic dilemma.
    Khanchel F; Hedhili R; Zenaidi H; Helal I; Yahmadi A; Ben Néji H; Ksontini F; Ben Brahim E; Jouini R; Chadli A
    Gen Thorac Cardiovasc Surg; 2021 Jul; 69(7):1155-1158. PubMed ID: 33866513
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Primary Atrial Undifferentiated Sarcoma Found on FDG PET/CT Mimicking Cardiac Myxoma.
    Wang R; Shen G; Tian R
    Clin Nucl Med; 2020 Oct; 45(10):833-835. PubMed ID: 32804771
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [SMARCA4-deficient primary thoracic sarcoma:a clinicopathological analysis of five cases].
    Zheng MJ; Zheng Q; Wang Y; Shen L; Zhu XZ; Li Y
    Zhonghua Bing Li Xue Za Zhi; 2019 Jul; 48(7):537-542. PubMed ID: 31288309
    [No Abstract]   [Full Text] [Related]  

  • 47. Left Forearm Langerhans Cell Sarcoma Demonstrated by 18 F-FDG PET/CT.
    He L; Deng Y; Huang J; Xie H; Zhang W
    Clin Nucl Med; 2022 Nov; 47(11):998-999. PubMed ID: 35835140
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pathological characteristics and immune microenvironment of SMARCA4-deficient undifferentiated uterine sarcoma.
    Gao J; Fan R; Chen D; Hou J; Chen H; Lu M
    Diagn Pathol; 2023 May; 18(1):62. PubMed ID: 37194064
    [TBL] [Abstract][Full Text] [Related]  

  • 49. (18)F-FDG positron emission tomography/computed tomography and (99m)Tc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease.
    Asabella AN; Cimmino A; Altini C; Notaristefano A; Rubini G
    Hell J Nucl Med; 2011; 14(3):311-2. PubMed ID: 22087457
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnosis of thoracic SMARCA4-deficient undifferentiated tumor in cytology.
    Kezlarian B; Montecalvo J; Bodd FM; Chang JC; Riedel E; White C; Rekhtman N; Sauter JL
    Cancer Cytopathol; 2023 Aug; 131(8):526-534. PubMed ID: 37278102
    [TBL] [Abstract][Full Text] [Related]  

  • 51. SMARCA4-Deficient Undifferentiated Tumor of Lung Mass-A Rare Tumor With the Rarer Occurrence of Brain Metastasis: A Case Report and Review of the Literature.
    Yadav R; Sun L; Salyana M; Eric M; Gotlieb V; Wang JC
    J Investig Med High Impact Case Rep; 2022; 10():23247096221074864. PubMed ID: 35356840
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A first described chest wall metastasis from colon cancer demonstrated with (18)F-FDG PET/CT.
    Jiang L; Gao Y; Sheng S; Xu M; Lu L; Lu H
    Hell J Nucl Med; 2011; 14(3):316-7. PubMed ID: 22087459
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Solitary Lymph Node Metastasis From a Malignant Peripheral Nerve Sheath Tumor of the Thoracic Vertebra Revealed on FDG PET/CT.
    Xiao L; Li Y; Li L
    Clin Nucl Med; 2022 May; 47(5):e419-e420. PubMed ID: 35234201
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Primary Hepatic Gastrointestinal Stromal Tumor on 18 F-FDG PET/CT Images.
    Jiang Y; Lu Q; Lou C; Huang Z
    Clin Nucl Med; 2023 Aug; 48(8):722-724. PubMed ID: 37220247
    [TBL] [Abstract][Full Text] [Related]  

  • 55. FDG-Avid Sclerosing Adenosis of the Breast Mimicking Malignancy.
    Zhang J; Yu Z; Dong A; Zhu Y
    Clin Nucl Med; 2022 Feb; 47(2):192-194. PubMed ID: 34319965
    [TBL] [Abstract][Full Text] [Related]  

  • 56. SMARCA4-deficient Uterine Sarcoma and Undifferentiated Endometrial Carcinoma Are Distinct Clinicopathologic Entities.
    Kolin DL; Quick CM; Dong F; Fletcher CDM; Stewart CJR; Soma A; Hornick JL; Nucci MR; Howitt BE
    Am J Surg Pathol; 2020 Feb; 44(2):263-270. PubMed ID: 31567195
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytologic Features of SMARCA4-Deficient Thoracic Sarcoma: A Case Report and Comparison with Other SWI/SNF Complex-Deficient Tumors.
    Matsushita M; Kuwamoto S
    Acta Cytol; 2018; 62(5-6):456-462. PubMed ID: 30286456
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The first case of SMARCA4-deficient sarcoma of stomach.
    Ota T; Ishikawa T; Yasuda R; Yasuda T; Okayama T; Inoue K; Dohi O; Yoshida N; Kamada K; Uchiyama K; Takagi T; Konishi H; Naito Y; Matsuyama K; Yamaguchi T; Ootsuka K; Yoshida A; Kishimoto M; Itoh Y
    Clin J Gastroenterol; 2022 Jun; 15(3):531-536. PubMed ID: 35175571
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.
    Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.